The nation of Zimbabwe has declined a substantial American healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' insistence on sensitive biological samples.
The decision was revealed after a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesman later explained that the US was demanding access to health data for research and commercial purposes while was not willing to guarantee the benefits from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged further dialogue to find a deal suitable to all parties so the country's critical HIV treatment initiative can continue.
Wider Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court suspended a related deal with the US after legal challenges were raised about the security of citizens' medical information.
After resuming office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and accountability.
Based on reports, Sixteen African countries have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our citizens should a new pandemic emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures already established through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This framework is intended to guarantee that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further discussions with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body expressed it recognised the official position, but urged that talks should continue given that much of the country's HIV programmes depended on international support.
"If specific concerns arise, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it commented.
This impasse emphasises the ongoing challenges between receiving much-needed international aid and protecting national sovereignty in an ever more interconnected world.